Ovarian cancer
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
Clinical implications of using molecular diagnostics for ovarian cancers
State of the art of surgery in advanced epithelial ovarian cancer
Surgical intervention in relapsed ovarian cancer is beneficial
Surgical intervention in relapsed ovarian cancer is beneficial
Do we have a new standard in suboptimal debulked disease?
Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients
Update on nonserous ovarian cancer trials
Update on randomized trials on recurrent disease
Integrating bevacizumab into the management of epithelial ovarian cancer
Targeted therapies and clinical trials in ovarian cancer†
Patient-reported outcomes in ovarian cancer clinical trials
New developments in the treatment of ovarian cancer—future perspectives